Abstract Residual cardiovascular risk despite intensive statin therapy necessitates additional management in patients with dyslipidemia. Icosapent, an ethyl ester of […]Read More.
Icosapent: New Panacea for Cardiovascular Risk Prevention?
Frailty in Myocardial Infarction Patients: A Paradigm Shift
Mariam Hassan1, Hanan Sheikh Ibrahim2, Samer Ellahham2,3 1.Gulf Medical University, Ajman, United Arab Emirates 2.Cleveland Clinic Abu Dhabi and Cleveland […]Read More.